Gilead Sciences | Lucro Operacional

Preço das Ações
152.50
Mudança Diária
3.13 2.10%
Mensal
22.64%
Anual
58.79%
Q1 Previsão
147.82




Lucro Operacional Alterar Data
AbbVie USD 5.81B 1.23B 2025-12
Agios Pharmaceuticals USD -116.87M 10.19M 2025-09
ALKERMES USD 89.08M 3.9M 2025-09
Alnylam Pharmaceuticals USD -29.96M 13.76M 2025-09
Amgen USD 3.96B 464M 2025-12
Biogen USD 659.6M 192.2M 2025-09
BioMarin Pharmaceutical USD -31.69M 308.58M 2025-09
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Eli Lilly USD 8.99B 599.9M 2025-12
Gilead Sciences USD 3.51B 810M 2025-09
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Glaxosmithkline GBP 3.76B 1.32B 2025-09
Incyte USD 431.31M 120.49M 2025-09
J&J USD 5.59B 1.81B 2025-12
Merck USD 6.24B 318M 2025-12
Moderna USD -260M 647M 2025-09
Neurocrine Biosciences USD 239.3M 93.7M 2025-09
Novartis USD 4.5B 363M 2025-09
Pfizer USD 4.65B 3.99B 2025-12
PTC Therapeutics USD 3.49M 38.35M 2025-09
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Sanofi EUR 1.7B 2.17B 2025-12
Sarepta Therapeutics USD -62.88M 178.46M 2025-09
United Therapeutics USD 389.3M 112.4M 2025-09
Vertex Pharmaceuticals USD 1.24B 84.6M 2025-09


Gilead Sciences Lucro Operacional - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.